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Abstract.  We investigated the influence of a glycosyl- 
phosphatidylinositol (GPI) anchor on the ectodomain 
of the influenza hemagglutinin (HA) by replacing the 
wild type (wt)  transmembrane and cytoplasmic do- 
mains with a GPI lipid anchor. GPI-anchored HA 
(GPI-HA) was transported to the cell surface with 
equal efficiency and at the same rate as wt-HA. Like 
wt-HA, cell surface GPI-HA, and its ectodomain 
released with the enzyme PI-phospholipase C  (PI- 
PLC), were 9S trimers. Compared to wt-HA, the 
GPI-HA ectodomain underwent additional terminal 
oligosaccharide modifications; some of these occurred 
near the receptor binding pocket and completely in- 
hibited the ability of GPI-HA to bind erythrocytes. 
Growth of GPI-HA-expressing cells in the presence of 
the mannosidase I inhibitor deoxymannojirimycin 
(dMM) abrogated the differences in carbohydrate 
modification and restored the ability of GPI-HA to 
bind erythrocytes. The ectodomain of GPI-HA pro- 
duced from cells grown in the presence or absence of 
dMM underwent characteristic low pH-induced con- 
formational changes (it released its fusion peptides and 
became hydrophobic and proteinase sensitive)  but at 
0.2  and 0.4 pH units higher than wt-HA, respectively. 
These results demonstrate that although GPI-HA 
forms a stable trimer with characteristics of the wt, its 
structure is altered such that its receptor binding activ- 
ity is abolished. Our results show that transmembrane 
and GPI-anchored forms of the same ectodomain can 
exhibit functionally important differences in structure 
at a great distance from the bilayer. 
1  ff'r~HE influenza virus hemagglutinin (HA)  is one of the 
l  best characterized  membrane glycoproteins in terms 
,i,  of its  structure,  functions,  biosynthesis,  and  mem- 
brane targeting. The structure of the HA trimer is known to 
high resolution (50). The glycoprotein functions as an adhe- 
sion molecule, a membrane fusion protein, and an immuno- 
gen (reviewed in 39, 47, 49). The primary translation prod- 
uct,  HAD, folds  and  oligomerizes  in  the  ER  to  form a 
homotrimer that is glycosylated and transported  to the cell 
surface through the constitutive secretory pathway (2, 7, 22). 
In polarized cells,  such as kidney epithelial cells and neu- 
rons, HA is targeted to specific membrane domains, the api- 
cal and axonal surfaces, respectively (15). Each mature HA 
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monomer contains two disulfide-linked polypeptide chains, 
HA1 and HA2. The HA1 subunit contains the receptor bind- 
ing site and major antigenic determinants; the HA2 subunit 
contains  the fusion peptide,  a sequence critical  for mem- 
brane fusion (reviewed in 39, 47, 49). 
HA is a type I integral membrane glycoprotein. Replace- 
ment of the HA transmembrane  and cytoplasmic domains 
with those from other glycoproteins can alter HA assembly, 
transport,  and subcellular localization (30, 35). Deletion of 
the HA transmembrane and cytoplasmic domains by the in- 
troduction of  translation termination codons can result in the 
synthesis and secretion of  improperly oligomerized polypep- 
tides (7, 22,  37). 
Unlike HA, many cellular proteins are embedded in mem- 
branes  via  a  glycosylphosphatidylinositol  (GPI)  anchor 
(reviewed in 3,  10,  18). Several GPI-anchored proteins are 
involved in cell-cell adhesion, for example NCAM-1, T-cad- 
herin, and sperm PH-20 (reviewed in 18, 41). Recently, an 
engineered GPI-anchored form of CD4 was shown to func- 
tion as a receptor for the HIV envelope glycoprotein (25, 
28).  Therefore,  both  naturally  occurring  and engineered 
GPI-anchored proteins function as cell adhesion molecules. 
Some GPI-anchored  molecules,  such as  LFA-3, NCAM-1 
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GPI-anchored forms (10),  and these alternative forms can 
behave differently. GPI-anchored NCAM-1 is transported to 
the  apical  surface  of polarized  epithelial  cells  (4,  33); 
transmembrane-anchored  NCAM-1  is  transported  to  the 
basolateral surface (33). The route (36) and rate (26) of en- 
docytosis of GPI-  and  transmembrane-anchored  proteins 
differ. In addition to transport differences, GPI and trans- 
membrane-anchored forms of the same polypeptide can have 
different activities. The lymphocyte surface molecules Ly-6/E 
and Qa-2 only activate T cells when present as GPI-anchored 
forms. The role of the GPI anchor in this process is, however, 
not understood (34, 40). 
The recent elucidation of the peptide sequences that signal 
GPI addition has led to the generation of several engineered 
GPI-anchored proteins (6, 9,  16, 25,  28,  31, 32, 46).  GPI- 
anchored chimeras including the heterodimeric T cell recep- 
tor and MHC class II polypeptides, the trimeric VSV G gly- 
coprotein, and the tetrameric Torpedo acetycholinesterase 
all  form  the  same  oligomers  as  their  transmembrane- 
anchored counterparts (9,  16, 31, 46). The PI-PLC-released 
ectodomains of GPI-anchored T cell receptor, MHC class II, 
and  acetycholinesterase remain  as  correct oligomers,  but 
detailed knowledge of their structures and functions is lack- 
ing (16, 31, 46). 
To gain insight into the influence that a GPI anchor can 
have on the structure and function of an oligomeric mem- 
brane  protein,  we  attached  a  GPI  anchor  to  the  well- 
characterized  influenza  HA.  We  then  studied  GPI-H.A/s 
oligomeric state, rate and efficiency of transport to the cell 
surface,  post-translational modifications,  receptor binding 
activity,  lateral  mobility,  conformational  changes  under 
fusion-inducing conditions, and, in a separate study (manu- 
script  in  preparation),  its  membrane  fusion  activity.  We 
show, for the first time, that the structure of a GPI-anchored 
protein can differ, in a functionally significant manner, from 
its transmembrane-bound counterpart. 
Materials and Methods 
Cells and Reagents 
All amino acid numbers for X:31 HA correspond to Ward and Dopheide 
(43). The nucleotide sequences encoding the X:31 HA ectodomain, excised 
by ClaI and BamHI digestion of the plasmid p72HR (a gift of P. Bates, 
University of California, San Francisco), and Decay Accelerating Factor 
(DAF) flanked by EcoRI sites (gift of D. Littman, University of California, 
San Francisco), were inserted into the corresponding restriction sites of 
pKSII+  (Stratagene Corp.,  San Diego,  CA) such that the open reading 
frames were in the same orientation, yielding pHADAE  The sequences 
between the desired portions of HA and DAF were deleted by standard 
mutagenesis  procedures  of  pHADAF  with  either  the  oligonucleotide 
DAFHA.TM (5  '-  G TC  TC~ATACAAAGAC  C CAAATAAAGGAAG  TGG-  3  ') 
or  DAFHA.BHA  (5'-CGGTTTCAGATCAAAGGTCCAAATAAAGGA- 
AGTGG-33  (UCSF BioMolecular Resource Center,  San Francisco, CA) 
(29).  These oligonucleotides appended the nucleotide sequence encoding 
the carboxy terminal 37 amino acids of DAF to the nucleotide sequences 
encoding the HA ectodomain.  The junctions were placed at  either the 
predicted point of membrane insertion (amino acid  184 of HA2) or the 
bromelain cleavage site (amino acid 175 of HA2) to generate the plasmids 
pGPI-HA and pGPI-BHA. Chimeras were confirmed by DNA sequence 
analysis with Sequenase 2.0 (US Biochemical Corp., Cleveland, OH). Se- 
quences encoding GPI-HA and GPI-BHA were isolated by digestion of 
pGPI-HA and pGPI-BHA with EcoRV and XbaI and ligated into XbaI- 
Sinai digested pEEl4 to yield pGSGPI-HA and pGSGPI-BHA (1). The 
nucleotide sequence encoding the entire HA coding region was excised from 
the plasmid pSVX38 (gift of M.-J. Gething, University of Texas, Dallas) by 
digestion with ClaI and Sail and inserted into ClaI and Sail digested pKSII+ 
(Stratagene Corp.) yielding the plasmid, pHA. The nucleotide coding se- 
quence of wild-type (wt)-HA, obtained by XbaI-SalI digestion of pHA and 
filling in the Sail site with the enzyme Klenow, was inserted into Xbal-SmaI 
digested pEEl4 to yield pEEHA (gift of T. Danieli, University of Califor- 
nia, San Francisco). 
CHO-K1 cells (American Type Culture Collection, Bethesda, MD, CCL 
61)  were  transfected using  the  standard  CaPO4  technique.  Cells  were 
grown for 10 d  in glutamine deficient minimal essential media (GIBCO 
BRL, Gaithersburg, MD) containing 10%  supplemented calf serum (Hy- 
clone,  Logan,  UT)  and  25  /~M  methionine sulfoximine (MSX,  Sigma 
Chemical Co., St. Louis, MO) as described (1). Individual colonies were 
isolated, expanded and replated at a density of 106 cells/10-cm dish in the 
presence of 400 ~tM MSX. After 10-14 d, individual clones were reisolated 
and grown continuously in the presence of 400/zM MSX. Cell lines ex- 
pressing a large amount of either wt-HA, GPI-HA, or GPI-BHA were cho- 
sen for further study. 
Cell Surface and Metabolic Labeling 
Total  cell surface proteins were labeled with an amine reactive biotin re- 
agent. Cells grown to confluency in 10-cm dishes were rinsed twice with 
ice cold PBS pH 7.8 and labeled in 3 ml of PBS, 1 mg/rnl immunopure NHS- 
LC-biotin (Pierce Biochemicals, Rockford, IL), pH 7.8 for 45 rain at 4°C. 
Excess reagent was quenched with two to three washes of ice cold PBS, 50 
mM glycine, pH 7.8. After immunoprecipitation, the biotinylated proteins 
were transferred to nitrocellulose (Schleicher and Schuell,  Inc.,  Keene, 
NH). The filters were blocked with PBS, 1% skim milk, 10% glycerol, 3% 
BSA,  1  M  glucose,  0.5%  Tween-20  and  incubated with  0.5  ng/ml  of 
streptavidin-HRP (Pierce Biochemicals) in PBS, 0.1% Tween-20 for 60 min 
at room temperature. The filters were washed three times in PBS, 0.5% 
Tween-20 and developed with the Enhanced Chemiluminescence reagent 
(Amersham Corp., Arlington Heights, IL) according to the manufacturer's 
instructions. 
Proteins were metabolically labeled by incubating cells in media lacking 
cysteine and methionine (cys-/met- MEM Select Amine) (GIBCO BRL) 
for 30 to 45 rain at 37°C. This media was removed and replaced by cys-/ 
met- media containing the indicated amount of [35S]TransLabel  (ICN, Ir- 
vine, CA) and 2 % supplemented calf serum. The cells were incubated for 
14 to  18 h at 37°C unless otherwise indicated before harvesting. 
Immunoprecipitation 
Cells expressing either wt-HA or GPI-HA were washed twice in PBS, and 
lysed on ice for 30 min in lysis buffer (1% NP-40,  100 mM Tris,  1 mM 
PMSE 1 p.g/ml pepstatin A, 2/~g/ml leupeptin, 4 ttg/ml aprotinin, 10 ttg/ml 
antipain, 50 p.g/ml benzamidine, 10 #g/ml soybean trypsin inhibitor (STI), 
0.5  mM  iodoacetamide (IAA)  (pH  7.5).  The  lysate was centrifuged at 
15,000 g in an Eppendorf microfuge for 20 min. The sample was incubated 
with 1/~g/ml of the site A mAb (gift of J. Skehel, Medical Research Coun- 
cil, Mill Hill, England) for 60 min at room temperature. The antibody-HA 
complexes  were  precipitated  with  protein  A  agarose  (Schleicher  and 
Schuell, Keene, NH) for 60 min at RT and washed extensively as described 
(27). 
Pulse Chase Analysis 
Approximately 106 cells were incubated for 30 min at 37°C in cys-/met- 
media. After this preincubation, the cells were pulse labeled for 8 min at 
37°C  with  100  /~Ci of [3SS]TransLabel  in cys-/met- media.  The chase 
period was initiated by replacing the cys-/met- medium with cys-/met- 
medium containing an excess of nonradioactive cysteine and methionine for 
the indicated period of time at 37°C. During the final 8 min of chase, trypsin 
was added to a final concentration of 10 p.g/ml at 37°C. Cells were then 
placed  on  ice  and  STI  was  added  to  100  #g/ml.  Samples  were  then 
processed by the addition of 0.1 vol of 10x  lysis buffer to the media and 
mixing. The resulting material was collected, incubated on ice for 30 min 
and centrifuged for 30 min at  15,000 g  in an Eppendorf microfuge. The 
resulting supernatant was immunoprecipitated. 
PI-PLC Treatment 
Cells were rinsed twice with PBS and incubated in PBS,  10 #g/ml BSA, 
100 mU/ml PI-PLC (Boehringer-Mannheim Corp., Indianapolis, IN). 
Fluorescence Photobleaching  Recovery (FPR) Analysis 
Polyclonal rabbit antiserum raised against virions of the X:31  strain was 
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lar Probes, Inc., Eugene, OR) were prepared from the IgG fraction as de- 
scribed following standard labeling procedures (19).  The Fab' preparation 
was free of contamination by F(ab')2 or IgG, as judged by SDS-PAGE un- 
der nonreducing conditions. The use of monovalent antibody fragments 
eliminates the possibility of IgG mediated cross-linking. 
Lateral diffusion coefficient (D) and mobile fractions (Rf) of wt-HA and 
GPI-HA on the surface of CHO cells were measured by FPR, using an ap- 
paratus described previously (19). Cells were split and grown on glass cov- 
erslips 2  d  before the experiment. They  were washed twice in  Hanks 
balanced salt solution with Earle's salts (HBSS; Beth Haemek, Israel), sup- 
plemented with 20 mM Hepes and 2% BSA (HBSS/Hepes/BSA, pH 7.2), 
and incubated with anti-HA TRITC-Fab' (100/~g/ml, 60 rain, 4°C). Alter- 
natively, they were labeled with the fluorescent lipid probe N-4-nitrobenzo- 
2-oxa-l,3-diazolyl-phosphatidylethanolamine  (N-NBD-PE, Avanti Polar Lip- 
ids, Inc., Pelham, AL) in I-IBSS/Hepes (devoid of BSA) as described earlier 
(19).  After rinsing three times, the coverslips were placed (cells facing 
downward) over a serological slide with a depression filled with the same 
buffer equilibrated at the desired temperature (37 or 220C). A thermostated 
microscope  stage  was  used  to  keep  the  sample  temperature  constant 
throughout the FPR experiment, performed within 45 min of labeling. The 
monitoring laser beam (529.5  nm, 1 #W, for TRITC; 488 nm, 0.1/~W,  for 
N-NBD-PE) was focused through the microscope (Zeiss Universal) to a 
Gaussian radius of (0.61 +/-  0.02) t~m with an xl00 oil immersion objec- 
tive. A brief pnise (5 mW, 30 ms, for TRITC; 0.5 mW, 60 ms for N-NBD- 
PE) bleached 50-70%  of the fluorescence in the illuminated region. The 
time  course  of fluorescence  recovery  was  followed by  the  attenuated 
monitoring beam. D and R/were extracted from the fluorescence recovery 
curves by nonlinear regression analysis (19). Incomplete recovery was inter- 
preted to represent fluoropbores that are immobile on the FPR experimental 
time scale (D ~  5  ×  10  -12 cm2/s). 
Cell Surface Cross-linking 
Approximately 106 cells were labeled with 250 t~Ci of [35S]TransLabel  for 
16 h, washed twice with HBS (10 mM Hepes, 150 mM NaCI, pH 8.0) and 
incubated  with  the  indicated  concentration  of  3,3'-dithiobis(sulfosuc- 
cinimidylpropionate) (DTSSP, Pierce Chemical Co., Rockford, IL) for 45 
rain at room temperature. Excess reagent was quenched by washing two 
times with HBS/50 mM glycine. The cells were washed one time with HBS 
and lysed by the addition of lysis buffer. After immunoprecipitation, the im- 
munecomplexes were suspended in 62.5 mM Tris pH 7.5, 2% SDS, 7.5% 
sucrose, 0.5 mM EDTA, 0.005 % bromophenol blue (loading buffer), heated 
to 95°C for 5 rain, separated on nonreducing 5% SDS-PAGE and fluoro- 
graphed with Amplify (Amersham Corp.). 
Gradient Analysis of  BHA, and PI-PLC-released 
GPI-HA and GPI-BHA 
Six T-175 flasks of cells expressing either wt-HA or GPI-HA and four T-175 
flasks of cells expressing GPI-BHA were metabolically labeled with 0.4 
mCi/flask of [35S]TransLabel  for 16 h.  The cells were incubated with 5 
#g/ml trypsin-TPCK (Sigma Chemical Co.) in RPMI-1640 for 5  rain at 
room temperature. The cleavage reaction was inhibited by the addition of 
50/~g/ml STI in RPMI-1640. The cells were washed twice in PBS/0.5 mM 
EDTA/0.5 mM EGTA, incubated in the same solution for 10 min at room 
temperature, and collected by centrifugation at 115 g for 5 min. For BHA 
preparations, the ceils were lysed for 30 rain on ice in lysis buffer.  After 
centrifugation in a TLA100.3 rotor (Beckman Instruments, PuUerton, CA) 
at 70,000 g for 30 min at 4"C, 2 betamercaptoethanol and bromelain were 
added to the lysate to final concentrations of 20 mM and 0.1 mg/ml, respec- 
tively. Digestion proceeded for 6 h at 37"C and was inhibited by the addition 
of 100  mM n-ethylmaleimide and the proteinase inhibitor cocktail de- 
scribed above. The ectodomalns of GPI-HA and GPI-BHA were released 
from intact cells by PI-PLC digestion as described above. BHA, PI-PLC- 
released GPI-HA, and PI-PLC-released GPI-BHA were purified by ricin 
sepharose chromatography as described (48).  The purified material was 
then applied to a continuous gradient of 5-25 % sucrose in 30 mM MES, 
150 mM NaC1, pH 7.0. The samples were centrifuged at 200,000 g for 16 h 
at 4°C in an SW-41 rotor (Beckman Instruments). Fractions were collected 
from the bottom of the tube and prepared for scintillation counting. 
Peptide N-Glycosidase F Digestion 
Approximately  10  ~ cells expressing either wt-HA or GPI-HA were in- 
cubated with 50/zCi of [35S]TransLabel  for 16 h. Cells were rinsed twice 
with PBS and lysed with lysis buffer.  The lysates were digested with 10 
t~g/ml of trypsin-TPCK for 30 rain at room temperature; inhibition was ter- 
minated by the addition of 100/~g/ml STI and the protease inhibitors de- 
scribed above. HA was immunoprecipitated, the immune,  complexes were 
boiled in a solution containing 1% octylglucoside, 0.1% SDS, 20 mM Tris 
pH 8.3,  10 mM EDTA, 1% BME for 10 min at 95°C, the sepharose beads 
were removed by centrifugation at  15,000 g for 10 s, and the supernatant 
was aliquoted. After cooling to room temperature, 1 #1 of Peptide N-gly- 
cosidase F  (Boehringer-Mannheim Corp.)  was  added  and  the proteins 
digested for 16 h at 37°C. An additional 1 t~l of Peptide N-glycosidase F 
was added and incubation continued for 7 h at 37°C. After addition of an 
equivalent amount of 2x sample buffer containing 100 mM DTT,  samples 
were heated to 95°C for 5 min and separated by 12%  SDS-PAGE. 
DMM Treatment of  Cells 
Approximately 106 cells expressing either wt-HA or GPI-HA were labeled 
with 100 #Ci of [35S]TransLabel  in the presence of 0.5 mM dMM (CalBio- 
chem, San Diego, CA) for 2 h at 37°C. After 2 h the cys-/met- medium 
was replaced with cys-/met- medium containing excess cysteine and me- 
thionine and 0.5 mM dMM for 2 h. The cells were briefly trypsinized with 
5/~g/ml of trypsin for 5 min and lysed. Wt-HA and GPI-HA were immuno- 
precipitated and separated by 10% SDS-PAGE. The gel was fluorographed 
with Entensify (New England Nuclear, Boston, MA). 
Red Cell Binding 
To analyze the receptor binding activity of HA, cells expressing either wt- 
or GPI-forms of HA were grown for 48 h in the presence or absence of  0.25 
mM dMM as indicated. Confluent monolayers were treated with 5 t~g/ml 
trypsin-TPCK and 0.2 mg/ml neuraminidase (Sigma Chemical Co.) for 10 
min at room temperature. The cells were washed twice with RPMI-1640 
and incubated with an 0.05 % suspension of washed human erythrocytes la- 
beled with octadecylrhodamine (Ris) as described (27) for 10 min at room 
temperature. Unbound RBCs were removed by six washes with RPMI-1640, 
and the cells were photographed. 
Proteinase K (PK) Digestion 
Cells  expressing  GPI-HA  or  wt-HA  were  metabolically  labeled  with 
[35S]TransLabel  for 16 h  in the presence or absence of 0.25 inM dMM. 
The cells were briefly trypsinized with 5 ttg/ml of trypsin-TPCK for 5 min 
at room temperature and removed from their dishes with PBS, 0.5 mM 
EDTA, 0.5 mM EGTA. The ectodomaln of GPI-HA was released by diges- 
tion with PI-PLC as described above. BHA was produced with bromelain 
that had been pretreated with reducing agent:  10 mg/ml bromelain was 
treated with 2 mM DTT for 10 min and the DTT removed by Sepharose 
G-25 filtration in an argon atmosphere. DTT-treated bromelain (0.1 mg/ml 
final concentration) was then added to a  suspension of intact wt-HA ex- 
pressing cells through which argon had been bubbled and incubation con- 
tinued for 16 h at 37"C. Digestion was inhibited by the addition of 100 mM 
NEM and  10  t~g/ml BSA followed by two successive centrifugations at 
15,000 g in an Eppendorf microfuge. Aliquots of 35S-labeled BHA and PI- 
PLC-released GPI-HA in MES-saline pH 7.0 were lowered to the indicated 
pH value by the addition of a predetermined amount of 0.1 M  citric acid 
and incubated for 15 min at 37°C. The samples were reneutralized by the 
addition of a  predetermined amount of 1.0 M  Tris base. CaC12 and PK 
were added to 2 mM and 0.2 mg/ml, respectively, and incubation continued 
for 30 min at 370C. The digestion was stopped by the addition of 1/~g BSA, 
1 mM PMSE and proteinase inhibitors. The proteins were immunoprecipi- 
tated with the site A mAb, separated by 10% SDS-PAGE and visualized by 
fluorography following treatment with Entensify. 
Triton X-II4 Partitioning 
Approximately 5  x  107 cells expressing either wt-HA or GPI-HA were la- 
beled with 3.0 mCi of [35S]TransLabel  for 18 h at 37"C. PI-PLC-released 
GPI-HA and BHA  were prepared as described above.  The 35S-labeled 
polypeptides were applied to a matrix of the site A mAb covalently cross- 
linked to protein A agarose (24). The unbound material was discarded and 
the column washed with 20 vol each of 12.5 mM potassium phosphate, pH 
7.4;  600 mM NaC1,  12.5  mM potassium phosphate, 300 mM NaCI, pH 
7.4; and 10 mM potassium phosphate pH 8.0. The bound protein was eluted 
with 100 mM triethylamine and immediately neutralized by the addition of 
1 M  potassium phosphate. The material was dialyzed overnight against 
Mes-saline at 4"C.  Purified BHA or PI-PLC-released GPI-HA was in- 
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to TX-II4 partitioning by the method of Bordier (13). The aqueous and de- 
tergent phases were separated and immunoprecipitated with the polyclonal 
anti-HA serum. Immunecomplexes were boiled, reduced and separated by 
10%  SDS-PAGE. 
Sucrose Gradient Sedimentation of CeU Surface HA 
Cell surface proteins were trypsinized with 5 /xg/ml trypsin for 5 min at 
room temperature and biotinylated. After biotinylation, the cells were re- 
moved from their dishes by incubation with PBS/0.5 mM EDTA/0.5  mM 
EGTA. The cells were resuspended in 1.0 mi MES-saline and aliquoted. 
One aliquot was lowered to pH 5.2 by the addition of 0.1 M citric acid and 
incubated for 10 min at 37°C. The cells were reneutralized, washed and 
lysed in lysis buffer. The lysates were clarified by centrifugation at 70,000 g 
in a TLA 100.3 rotor for 30 min at 4°C. The supernatants were applied to 
a 5-25% sucrose gradient containing 0.1% NP40 in MES-saline. 14 frac- 
tions were recovered, immunoprecipitated with the site A mAb, and sepa- 
rated by 10% SDS-PAGE. The proteins were transferred to nitrocellulose, 
probed with  streptavidin-HRP conjugate and  developed with  enhanced 
chemiluminescence. 
Results 
Construction of GPI-anchored HA 
To evaluate the influence of a GPI anchor on the ectodomain 
of a type I integral membrane glycoprotein, we constructed 
GPI-anchored forms of  the well-characterized influenza HA. 
Replacement of the normal transmembrane and cytoplasmic 
domains of several other type I integral membrane glycopro- 
teins with the carboxy terminal 37 amino acids of DAF con- 
fers GPI anchor addition (6, 28, 31).  We constructed GPI- 
HA and GPI-BHA (Fig. 1) by appending this 37 amino acid 
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Figure 1.  Structure of the GPI-HA and GPI-BHA chimeras. The 
top diagram depicts wt-HA: the ectodomain (D), transmembrane 
polypeptide (..), and cytoplasmic domain (1~) are indicated. The 
arrow marks the position of the HAl-HA2 proteolytic cleavage site. 
The middle and bottom diagrams depict the GPI-(B)HA chimeras, 
indicating the relative location of the hydrophobic region of DAF 
(m). The amino acid sequence beneath each diagram identifies the 
junction between the HA ectodomain and either the HA transmem- 
brane (white letters; wt-HA)  or the 37 amino acid GPI-anchor addi- 
tion  sequence from DAF (bar under sequences; GPI-HA, GPI- 
BHA). The numbers refer to the amino acid position in the HA2 
subunit (43). The asterisk over the Ser in the DAF indicates the 
predicted point of attachment for the GPI anchor (32). 
signal to sequences encoding the HA ectodomain at either 
the transmembrane junction (amino acid 184 of HA2; GPI- 
HA) or at the bromelain cleavage site (amino acid  175 of 
HA2;  GPI-BHA).  GPI-HA,  which  has  the  GPI  anchor 
added at the point of predicted membrane insertion, is analo- 
gous to other GPI-anchored chimeras (6, 9,  16, 25, 28,  31, 
32, 46). GPI-HBA was constructed because its ectodomain 
would be analogous to the highly characterized BHA mole- 
cule (49). Because GPI-HA contains the complete HA ec- 
todomain, it was characterized in greater detail; however, 
both polypeptides behaved identically in all assays.  CHO 
cells that stably express high levels of GPI-HA, GPI-BHA, 
and  wt-HA  were  isolated  as  described  in  Materials  and 
Methods. 
Expression and Transport of GPI-HA to the 
Cell Surface 
We first tested whether GPI-HA and GPI-BHA are trans- 
ported to the cell surface. CHO cells do not proteolytically 
process the nonfusogenic HA0 into the disulfide-linked HA1 
and  HA2 subunits  (23,  27).  We therefore determined the 
amount of HA transported to the cell surface using a trypsin- 
sensitivity assay (7). Cells expressing either GPI-HA, GPI- 
BHA or wt-HA were metabolically labeled with psS]Trans- 
Label for 18 h, briefly trypsinized, and lysed. The lysates 
were immunoprecipitated with an anti-HA mAb and sepa- 
rated by SDS-PAGE (Fig. 2 a).  The GPI-anchored forms, 
like wt-HA, were produced as the HA0 precursor (Fig. 2 a, 
lanes without trypsin).  Phosphorimager analysis indicated 
that, upon addition of exogenous trypsin, •85  % of total cel- 
lular wt-HA0, GPI-HA0 and GPI-BHAD were cleaved into 
their HA1 and HA2 polypeptide chains (Fig. 2 a, lanes plus 
trypsin),  and that roughly equivalent amounts of wt-HA, 
GPI-HA and GPI-BHA were expressed at the cell surface. 
Indirect immunofluorescence  of  nonpermeabilized cells con- 
firmed the cell surface localization of GPI-HA and  GPI- 
BHA (data not shown).  These results indicated that GPI- 
HA0 and GPI-BHA0 reach the cell surface efficiently and can 
be cleaved to generate the HA1  and HA2 polypeptides. 
The HA0, HA1, and HA2 polypeptide chains of the GPI- 
anchored HAs migrated differently than their wt counter- 
parts  on  SDS  gels  (Fig.  2  a).  The  estimated  molecular 
weights of GPI-HA2 and GPI-BHA2 were consistent with 
carboxy terminal processing and GPI anchor addition (32). 
The slower migration of GPI-HA2 relative to GPI-BHA2 
(Figs.  1 and 2 a) is consistent with the 9 amino acid differ- 
ence  between  GPI-HA2  and  GPI-BHA2.  However,  the 
slower migration of GPI-HA1  and GPI-BHA1 (relative to 
HA1) could not be accounted for by differences in protein 
mass, because these subunits have identical primary struc- 
tures  (Fig.  1).  Posttranslational modifications,  specifically 
terminal glycosylation, slowed the migration of GPI-HA1 
and GPI-BHA1 relative to HA1  (see below). 
We next tested whether the GPI anchor altered the rate ot 
transport of the  HA  ectodomain through the  constitutive 
secretory pathway.  Cells expressing either wt-HA or GPI- 
HA were pulse labeled with  [35S]cysteine and methionine 
for 10 min and chased for various intervals (Fig. 2 b). Durin~ 
the last 8 rain of the chase trypsin was added to convert cel 
surface  wt-HA0  and  GPI-HA0  to  their  disulfide-linkex 
subunits.  The approximate tl/2 for appearance of both wt 
HA and GPI-HA at the cell surface was 50 min and both mol 
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(A) Transport to the cell surface was assessed by trypsinization of 
intact cells. Cells expressing either wt-HA, GPI-HA, or GPI-BHA 
were labeled with I~ss] for 18 h then treated with 10 #g/ml trypsin 
(+) or STI (-) for 10 min at room temperature. Equivalent amounts 
of  each lysate were immunoprecipitated with the site A mAb, sepa- 
rated by SDS  10% PAGE, and autoradiographed.  The arrows on 
the left indicate the positions of the wt-HA subunits and the arrows 
on the fight mark the positions  of the GPI-(B)HA subunits.  (B) 
Pulse chase analysis of wt-HA and GPI-HA in CHO derived cell 
lines. Cells expressing either wt-HA (circles; solid line) or GPI-HA 
(squares; hashed line) were  pulsed  for 8 min with  100 #Ci of 
[3sS]TransLabel. The  chase was  initiated  by replacing  the  [35S] 
containing media with media containing an excess of cysteine and 
methionine. During the final 8 min of the chase period, trypsin was 
added to 10 #g,/ml to cleave cell surface HA. STI was added, total 
HA immunoprecipitated,  boiled,  reduced,  and separated by 10% 
SDS-PAGE.  The  autoradiogram  was  quantitated  by  phosphor- 
imager analysis and the amount of HA1 and HA2 (a.u., arbitrary 
units) is plotted with respect to the time of chase. 
ecules were stable for at least 6 h. GPI-HA is therefore trans- 
ported to the cell surface with approximately the same rate 
and efficiency as wt-HA (Fig.  2). 
Membrane Attachment of GPI-HA 
We predicated  that  GPI-HA and  GPI-BHA would  be an- 
chored in the membrane by a GPI moiety (6, 31). To test this 
prediction we treated intact biotinylated cells with PI-PLC 
(18). The media and cells were then immunoprecipitated with 
an anti-HA antibody and probed with streptavidin-HRP (Fig. 
3).  Wt-HA was exclusively associated with the cell pellet 
whether it was or was not treated with PI-PLC (Fig. 3, lanes 
1-4). In the absence of PI-PLC, GPI-HA and GPI-BHA re- 
mained with the cell pellet (Fig. 3, lanes 5, 6, 9, 10).  How- 
ever,  PI-PLC released a  large proportion of GPI-HA and 
GPI-BHA into the supernatant (Fig.  3,  lanes  7,  8,  11,  12). 
The GPI-HA and GPI-BHA remaining with the cell pellet 
after PI-PLC treatment may contain modifications that ren- 
der the GPI anchor resistant to PI-PLC (42). These findings 
demonstrated that GPI-HA and GPI-BHA are anchored to 
the membrane via a GPI moiety, and that their ectodomains 
can be released by digestion with PI-PLC. 
Lateral Mobility of GPl-anchored HA 
Where  studied,  GPI-anchored  proteins  diffuse  approxi- 
mately two times faster than their transmembrane-anchored 
counterparts (52).  The lateral diffusion coefficient of GPI- 
HA was  10  x  10  -10 cm2/s at 37°C  (Table I) compared to 
5  x  10  -10 cmVs for wt-HA, consistent with previous find- 
ings on wt-HA from a different influenza virus strain (19). 
Approximately  65%  of  GPI-HA  was  mobile,  similar  to 
wt-HA (Table I). Thus, like other GPI-linked proteins, GPI- 
HA  diffuses  twofold  more  rapidly  than  transmembrane- 
anchored HA (52).  The high Re values which are close to 
those observed for a phospholipid probe under the same con- 
ditions (Table I), indicated that GPI-anchored HA diffuses 
freely in the membrane, and is not segregated into special- 
ized membrane domains (17). 
Oligomeric Form of GPI-anchored HA on the 
Cell Surface 
Improperly folded or oligomerized forms of HA do not reach 
the cell surface (7, 22,  37). Because GPI-HA is transported 
to the cell surface (Fig. 2), it is likely a tfimer. To test this 
prediction, cells expressing wt-HA or GPI-HA were meta- 
bolically labeled and cross-linked with the membrane im- 
permeable crosslinker, DTSSP.  Cell lysates were prepared, 
Figure 3.  PI-PLC release  of GPI-HA and  GPI- 
BHA from the cell surface. Cells expressing either 
wt-HA or GPI-HA  were biotinylated and the intact 
cells were treated with (+PLC) or without (-PLC) 
PI-PLC for 60 rain at 37°C. The media (S) and cell 
pellets (P) were harvested separately and prepared 
for immunoprecipitation with the site A mAb. The 
immunecomplexes  were  reduced,  separated  on 
SDS  10%  PAGE, probed with  streptavidin-HRP 
and developed with ECL. The position of  HA0 and 
GPI-H/~) arc indicated. 
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CHO Cells 
Membrane component 
labeled  Temperature  D × 10  -~°  R/ 
°C  cm~/s 
wt-HA  37  4.9  +  0.4  75  +  3 
22  1.9  +  0.3  70 +  6 
GPI-HA  37  9.9  +  1.1  67 +  3 
22  2.5  +  0.3  64 +  5 
N-NBD-PE  37  43  +  4  80 ±  3 
22  21  +  2  77 +  5 
CHO cells expressing wt-HA  and GPI-HA  were prepared for lateral mobility 
measurements as described in Materials and Methods. 
immunoprecipitated  with  an  anti-HA  antibody,  and  sepa- 
rated on nonreducing 5 % SDS polyacrylamide gels (Fig. 4). 
In the absence of cross-linker, wt-HA migrated as three dis- 
tinct species corresponding to monomer, dimer and trimer 
(Fig. 4, lane/). Interactions among the transmembrane and 
cytoplasmic domains account for the association of wt-HA 
monomers on nonreducing SDS-gels. BHA, which lacks the 
transmembrane and  cytoplasmic domains,  migrates  com- 
pletely as a monomer on nonreducing SDS gels (see 12 and 
Fig.  5 a, inset).  Addition of 10 mM DTSSP to wt-HA in- 
creased the proportion of the trimer band (Fig. 4,  lane 2). 
In the absence of cross-linker, GPI-HA migrated completely 
as a  monomer (Fig.  4,  lane 3).  Upon addition  of DTSSP, 
however, a band corresponding to a GPI-HA trimer, and a 
Figure 4. Oligomeric form of GPI-HA on the cell surface. (A) Cell 
surface cross-linking of intact cells. Cells expressing either wt-HA 
or GPI-HA were labeled with  [35S]TransLabel for 18 h at 37"C 
and treated with the indicated concentration of 13ffSSP for 45 min 
at room temperature.  After quenching  excess reagent,  the  cells 
were lysed, and immunoprecipitated with the site A mAb. The im- 
munecomplexes were boiled in the presence of SDS and separated 
by non_reducing 5% SDS-PAGE. The position of the trimeric (T), 
dimeric (D) and monomeric (M) forms are indicated. 
weaker band corresponding to a  GPI-HA dimer (see also 
Fig. 5 b), appeared (Fig. 4, lane 4).  Moreover, cell surface 
GPI-HA cosedimented with 9S trimers of wt-HA on 5-25 % 
sucrose gradients (see Fig. 10). These analyses indicated that 
GPI-HA is present at the cell surface as a 9S trimer. Unlike 
transmembrane-anchored  HA,  but  identical  to  BHA,  the 
GPI-HA trimer is not stable in SDS. 
Oligomeric Form of  GPI-HA Released with PI-PLC 
The  water  soluble  ectodomain  of wt-HA  prepared  with 
bromelain, BHA, retains the oligomeric structure of mem- 
brane-bound HA (47, 49). To establish the oligomeric struc- 
ture of PI-PLC-released GPI-HA, cells expressing wt-HA, 
GPI-HA, or GPI-BHA were metabolically labeled, treated 
with bromelain or PI-PLC, and separated on 5-25 % sucrose 
gradients.  PI-PLC-released GPI-HA and GPI-BHA cosedi- 
mented with 9S BHA trimers (Fig. 5). The presence or ab- 
sence of nonionic detergent did not change these sedimenta- 
tion profiles (data not shown). A sample of the peak fraction 
(No.  11) from the BHA and PI-PLC-released GPI-HA and 
GPI-BHA  gradients  was  removed  and  cross-linked  with 
DTSSP.  As shown in Fig. 5 (insets), both BHA and PI-PLC- 
released GPI-(B)HA migrated as monomers on nonreducing 
SDS gels (12).  Upon addition of DTSSE however, dimeric 
and  trimeric  forms  of  BHA  and  PI-PLC-released  GPI- 
(B)HA were detected (Fig. 5, insets).  Therefore, both sedi- 
mentation  and  cross-linking  analyses  indicated  that  GPI- 
(B)HA,  like BHA,  remains trimeric after release from its 
membrane anchor. 
The Ectodomain of GPI-HA Contains 
Additional Oligosaccharides 
BHA contains seven N-linked oligosaccharide chains, six on 
the  HA1  subunit.  Two of the  oligosaccharide  chains,  at- 
tached to asparagine residues HA1  165 and HA1 285 retain 
the  high  mannose  form  (50).  GPI-HA1  and  GPI-BHA1 
migrated slower than wt-HAl in SDS-PAGE (see Fig. 2 a and 
Fig.  6  a).  To test whether additional oligosaccharide pro- 
cessing accounted for this slower mobility, we treated GPI- 
HA, GPI-BHA and wt-HA with Peptide N-glycosidase F to 
remove N-linked  oligosaccharide  chains.  After  this  treat- 
ment the  core polypeptides of all  HA1  subunits  migrated 
identically (Fig. 6 a). Consistent with this observation, GPI- 
HA1 and GPI-BHA1 were completely resistant, unlike wt- 
HA1, to digestion with EndoH (data not shown), indicating 
that GPI-anchored HA1  subunits  do  not  contain  any high 
mannose oligosaccharide chains. Thus, GPI-HA1 and GPI- 
BHA1  contain  more terminally processed oligosaccharide 
chains than wt-HA1. 
Treatment of cells with dMM inhibits mannosidase I activ- 
ity,  yielding glycoproteins that contain only high mannose 
oligosaccharide  chains  (5).  dMM  treatment  of influenza 
virus-infected cells prevents the addition of complex oligo- 
saccharide chains to (wt-)HA yet has no effect on virus bind- 
ing or infectivity (5). Wt-HA-expressing cells were grown in 
the  presence  of dMM  and  labeled  with  [35S]TransLabel. 
After  brief  trypsinization  and  immunoprecipitation,  we 
found that the wt-HA1 subunit from cells grown in the pres- 
ence of dMM migrated faster than wt-HA1 from cells grown 
in normal media (Fig. 6 b). In a similar manner, growth of 
GPI-HA-expressing cells in medium containing dMM pro- 
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PI-PLC-released GPI-HA  and 
GPI-BHA. Gradient  analysis 
of BHA and PI-PLC-released 
GPI-HA and GPI-BHA. Cells 
expressing  wt-HA (A),  GPI- 
HA  (B),  and  GPI-BHA (C) 
were labeled  with l~SS]Trans  - 
Label for 20 h, briefly  tryp- 
sinized  and  harvested.  Cells 
expressing wt-HA were treated 
with  bromelain  as  described 
and  cells  expressing  GPI- 
(B)HA were digested with PI- 
PLC for 60 min at 37°C. The 
released  material was affinity 
purified  on  ricin  sepharose 
and  applied  to  a  5-25% 
sucrose  gradient.  After  sed- 
imentation,  fractions  were 
collected  and  monitored  by 
scintillation  counting.  The 
cpm for each fraction is plotted 
with  respect  to  the  fraction 
number.  (InseO An aliquot of 
the  peak  fraction from each 
gradient  was  removed  and 
treated  with  (+)  or  without 
(-) 5 mM DTSSP for 30 min 
at room temperature.  The re- 
action was quenched and the 
material  immunoprecipitated 
with the Site A mAb. The im- 
munecomplexes  were  sepa- 
rated  on  nonreducing  10% 
SDS-PAGE  and  subjected  to 
autoradiography.  The position 
of  the  monomeric  (M),  di- 
meric  (/9)  and  trimeric  (T) 
species  are indicated. 
duced a GPI-HA1 subunit that migrated faster than GPI-HA1 
produced in the absence  of dMM  (Fig.  6  b).  Importantly 
however,  the  GPI-HA1  and  wt-HA1  subunits  from  cells 
grown in the presence of dMM migrated identically to one 
another, consistent with the hypothesis that dMM treatment 
generates glycoproteins containing only high marmose oli- 
gosaccharide chains (5). Subsequent EndoH digestion of wt- 
HA and GPI-HA produced  in the presence  of dMM  con- 
firmed that all of  the oligosaccharide chains on HA produced 
in  this  manner  were  in  the  high  mannose  form  (data  not 
shown).  These  results  demonstrated  that GPI-HA1 under- 
goes additional terminal oligosaccharide processing relative 
to  wt-HA1,  specifically  to  the  oligosaccharide  chains  at- 
tached to asparagine HA1  165 and/or HA1 285. 
Additional Oligosaccharide Processing of GPI-HA 
Abolishes Its Ability to Bind Erythrocytes 
Wt-HA binds sialic acid residues on the surface of host cell 
membranes via a receptor binding pocket found near the tip 
of the  HA  molecule  (44).  As  shown  in  Fig.  7,  wt-HA- 
expressing cells bound large numbers of erythrocytes which 
contain a large amount of sialic acid on their surface. Cells 
expressing  GPI-HA or  GPI-BHA,  however,  did  not  bind 
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HA. (A) N glycanase F digestion of wt-HA, GPI- 
HA,  and GPI-BHA. Cells expressing either wt- 
HA,  GPI-HA,  or GPI-BHA were labeled  with 
[35S]TransLabel for 16 h  at 37°C, briefly tryp- 
sinized, lysed, and the HA precipitated with the 
site A mAb. The immunecomplexes were boiled, 
reduced, and digested with Nglycanase F for 18 h 
at 37°C. The samples were again boiled, reduced, 
and  separated  on  12%  SDS-PAGE and  fluoro- 
graphed. The positions of the polypoptides before 
and  after ("Core") N-glycanase F  digestion  are 
marked.  (B) Growth of cells in the presence of 
dMM alters the glycosylation of wt-HA and GPI- 
HA. Cells expressing wt-HA or GPI-HA were la- 
beled with [35S]TransLabel  in the presence (+) or 
absence (-) of 0.25 mM dMM for 18 h at 37°C. 
The cells were briefly trypsinized, lysed, and the 
HA immunoprecipitated. Immunecomplexes were 
boiled,  reduced,  separated on 10%  SDS-PAGE, 
and fluorographed. The positions of the polypep- 
tides are marked. 
erythrocytes indicating a  loss of receptor binding activity 
(Fig. 7). Because GPI-HA and GPI-BHA contain additional 
oligosaccharide modifications, which could be prevented by 
production in the presence of dMM, we tested the ability of 
dMM-treated  HA-expressing  ceils  to  bind  erythrocytes. 
Consistent with  previous results,  wt-HA produced in  the 
presence of dMM bound erythrocytes as well as wt-HA pro- 
duced in normal medium (Fig. 7) (5).  Growth of GPI-HA 
and GPI-BHA-expressing cells in dMM restored their eryth- 
rocyte binding activity (Fig. 7). We conclude, in combina- 
tion with the preceding analysis,  that processing of addi- 
tional oligosaccharide chains to complex forms abolishes the 
ability of GPI-HA and GPI-BHA to bind erythrocytes. This 
defect can be fully alleviated, however, by growth of GPI- 
(B)HA-expressing cells in dMM. 
Low pH-induced Conformational Changes of the 
GPI-HA Ectodomain 
The water soluble BHA ectodomain undergoes characteris- 
tic low pH-induced conformational changes like wt-HA (13, 
47,  49).  We therefore asked whether the GPI-HA ectodo- 
main undergoes these changes. We first measured the pH at 
which GPI-HA becomes proteinase sensitive. We incubated 
35S-labeled BHA or PI-PLC-released GPI-HA at different 
pH  values  for  15  min  at  37°C,  and  then  reneutralized, 
digested with Proteinase K (PK), and analyzed the samples 
on 10% SDS-PAGE (Fig. 8). As shown previously, BHA was 
not susceptible to degradation by PK unless it was treated be- 
low pH 5.4. Growth of cells expressing wt-HA in dMM did 
not alter this  pattern.  PI-PLC-released GPI-HA was  also 
resistant to the action of PK at pH 7.0, but it became suscepti- 
ble below pH  5.8. GPI-BHA behaved similarly  (data  not 
shown). PI-PLC-released GPI-HA produced in the presence 
of dMM became PK sensitive after treatment below pH 5.6. 
This  analysis  indicated  that,  like  BHA,  PI-PLC-released 
GPI-HA becomes PK sensitive after exposure to low pH. 
However, proteinase K sensitivity occurs at 0.4 and 0.2 pH 
units higher than for BHA when produced in the absence or 
presence of dMM,  respectively. In terms of its pH depen- 
dence,  GPI-HA  behaves  like  HA  mutants  that  display 
elevated fusion pH dependencies due to point mutations in 
the ectodomain (49). 
Low pH treatment causes BHA to become hydrophobic 
(13, 47, 49). We determined whether PI-PLC-released GPI- 
HA becomes hydrophobic by measuring its ability to parti- 
tion  into  the  detergent TX-114.  35S-labeled  BHA  and  PI- 
PLC-released GPI-HA were incubated at pH 7.0 or pH 5.2 
for 15 min at 37°C, reneutralized, and extracted with TX-114 
(13).  The detergent and aqueous phases were separated, ad- 
justed to similar compositions and immunoprecipitated with 
the anti-HA serum. As shown in Fig. 9, both BHA and PI- 
PLC-released GPI-HA partitioned into the aqueous phase at 
neutral pH. After treatment at low pH, however, both BHA 
and PI-PLC-released GPI-HA partitioned into the detergent 
phase (Fig. 9). Under these conditions over 90% of the GPI- 
HA and GPI-BHA (data not shown) partitioned into the de- 
tergent phase.  These results demonstrated that, like BHA, 
PI-PLC-released GPI-(B)HA acquires hydrophobic proper- 
ties after low pH treatment. 
Low pH induces hydrophobic properties in BHA due to re- 
lease of the fusion peptides from the trimer interface (48). 
We therefore tested whether the fusion peptides are exposed 
from PI-PLC-released GPI-HA.  35S-labeled BHA and PI- 
PLC-released GPI-HA were incubated at pH 7.0 or 5.2 for 
5 min at 37°C, reneutralized, and incubated with an antise- 
rum to the fusion peptide. As shown in Table 1I, the neutral 
pH forms of BHA and PI-PLC-released GPI-HA did not re- 
act with the fusion peptide antiserum. After low pH treat- 
ment, however, the fusion peptides in both molecules were 
detected with the anti-fusion peptide antiserum. Conversely, 
two neutral pH  specific epitopes located at the tip of the 
tfimer, whose reactivities are lost concomitant with fusion 
peptide exposure (27), were only recognized in the neutral 
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on  the  erythrocyte  binding 
activity  of wt-HA, GPI-HA, 
and  GPI-BHA.  Cells  were 
grown in the presence (right) 
or absence  (left) of 0.25 mM 
dMM  for  48  h.  Confluent 
monolayers  of  cells  were 
briefly treated with 0.2 mg/ml 
neuramim'dase  and  5  /~g/ml 
trypsin for 5 min at RT before 
incubation  with  R~8  labeled 
human erythrocytes. Unbound 
erythrocytes were removed by 
several  washes  and  the  ceils 
photographed with both phase 
contrast and fluorescence mi- 
croscopy. The phase contrast 
is  shown  for the  wt-HA ex- 
pressing  cells  only (top); all 
other fields contain an equiva- 
lent  density  of  cells.  Cells 
transfected  with  only  the 
pEEl4 vector are in the bot- 
tom panels (MOCK). 
pH forms of both molecules (Table II). Collectively, these 
results indicate that PI-PLC-released GPI-HA adopts hydro- 
phobic properties after treatment at low pH due to conforma- 
tional changes that include exposure of the fusion peptides. 
Oligomeric Structure of Low pH-Treated GPI-HA 
Although wt-HA changes conformational at low pH, it re- 
mains trimeric (12).  We therefore determined whether GPI- 
HA remains trimeric after exposure to low pH. Intact cells 
expressing wt-HA or GPI-HA were biotinylated, exposed to 
either pH 7.0 or pH 5.2 for 10 rain at 37°C, neutralized, and 
lysed. Lysates were separated on 5-25 % sucrose gradients 
and immunoprecipitated (Fig.  10).  The neutral pH forms of 
membrane-bound wt-HA and GPI-HA cosedimented in the 
position of9S trimers (Fig. 10). Although the low pH-treated 
samples migrated somewhat slower than their neutral pH- 
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BHA and PI-PLC-released  GPI-HA with pH 
Specific Antibodies 
BHA  PI-PLC GPI-HA 
Antibody  pH7  pH5  A  pH7  pH5 
Fusion peptide  0  109  +109  8  89  +81 
N1  87  3  -84  94  4  -90 
N2  92  0  - 92  87  0  - 87 
35S-labeled BHA and PI-PLC-released  GPI-HA  were prepared as described in 
the legend  to Fig. 9. Samples  were either maintained at pH7 or treated at pH5, 
renentralized,  and  immunoprecipitated with the  indicated antibodies as 
described in reference 27. Values represent the percent of HA precipitated. 
Figure 8. Proteinase K digestion of  BHA and PI-PLC-released GPI- 
HA and the effect ofdMM on the pH of  the conformational change. 
Cells  expressing  either  wt-HA  or  GPI-HA  were  labeled  with 
[35S]TransLabel for 18 h at 37°C in the absence (-dMM) or pres- 
ence (+dMM) of  0.25 mM dMM. BHA and PI-PLC-released GPI- 
HA were prepared  as described  in Materials  and  Methods  and 
aliquots of  each sample were treated at the indicated pH by the addi- 
tion of a predetermined amount of 0.1 M citric acid for 15 min at 
37°C. The samples were reneutralized  and digested with 0.2 mg/ml 
PK for 30 rain at 37°C. The digestion was stopped by the addition 
of  PMSF and the samples immunoprecipitated with the site A mAb. 
Immunecomplexes were boiled, reduced, separated  on 10% SDS- 
PAGE, and subjected to fluorography. The pH of each sample is in- 
dicated above and the position of the HA1 polypeptide is indicated 
next to each lane. 
treated  counterparts,  low pH-treated  membrane-bound wt- 
HA and GPI-HA sedimented similarly (Fig.  10). Chemical 
cross-linking  of the  peak  fractions  from  these  gradients 
demonstrated the presence of trimers  in all cases (data not 
shown).  This  analysis  indicated  that GPI-HA remains  tri- 
meric after exposure to fusion-inducing conditions. 
Discussion 
Many cellular proteins are tethered to membranes via GPI 
anchors (3,  10,  18).  Transmembrane and GPI forms of the 
same polypeptide can differ in their rate and route of endocy- 
tosis, their destination in polarized cells, or their function (4, 
26, 33). For the Qa-2 and Ly-6/E lymphocyte surface mole- 
cules, the GPI anchor is essential for signaling function (34, 
40).  In none of these cases, however, is the role of the GPI 
anchor understood in terms of the structure of the glycopro- 
tein ectodomain. In this report we assessed the consequences 
of GPI anchorage on the assembly, posttranslational  modi- 
fications, lateral mobility, conformational changes, and re- 
ceptor binding activity of the well-characterized  influenza 
HA. We found that GPI-anchored HA forms stable, laterally 
mobile trimers that are transported to the cell surface with 
the same efficiency and rate as wt-HA. Their ectodomains, 
which can be released as stable trimers with PI-PLC, change 
conformation, expose their fusion peptides, and become hy- 
drophobic at low pH.  Therefore,  in many respects  the ec- 
todomain of GPI-anchored HA appears identical to that of 
wt-HA.  However,  GPI-anchored-HA undergoes additional 
oligosaccharide  processing  which  completely blocks  H/is 
receptor  binding  activity.  We believe  this  difference  is  at- 
tributable  to the GPI-anchor because chimeras containing 
the HA ectodomain and the juxtamembrane (both sides) and 
transmembrane domains of other viral glycoproteins bind to 
and fuse with target membranes like wt-HA (14,  35). 
In wt-HA (X:31 strain) two oligosaccharide chains retain 
the high mannose form. One is near the "~nge region" and 
the other is at Asn 165 which lies within 7/k of the receptor 
binding  site  (Fig.  11).  Additional oligosaccharide process- 
ing, either by growth of virus in MDBK cells (8,  11) or by 
introducing  a  new  oligosaccharide  addition  site  near  the 
receptor binding pocket (20), inhibits Hgs receptor binding 
activity. We propose that terminal processing of  the oligosac- 
charide chain at Ash 165 of GPI-anchored HA abolishes its 
erythrocyte binding activity by filling or masking the recep- 
tor pocket on a  neighboring monomer (Fig.  ll). 
Figure 9.  TX-114  partitioning  of BHA and  PI- 
PLC-released GPI-HA. Cells expressing  wt-HA 
and GPI-HA were labeled  with  [35S]TransLabel 
for 18 h at 37°C in the presence of  0.25 mM dMM. 
BHA  and  PI-PLC-released  GPI-HA were  pre- 
pared as described in Materials  and Methods. The 
samples  were treated  at pH 7.0 or pH 5.2 for 15 
min at 37°C, reneutralized  and extracted with TX- 
114. The detergent  (D) and aqueous (A) phases 
were separated and immunoprecipitated with anti- 
HA serum. The immunecomplexes  were reduced, 
boiled, and subjected  to 10% SDS-PAGE and au- 
toradiography. 
The Journal of Cell Biology, Volume 122, 1993  1262 Figure 10. Sucrose gradient analysis of  cell surface 
wt-HA and GPI-HA before and after low pH treat- 
ment.  Intact ceils  were  briefly  trypsinized,  bi- 
otinylated, and treated at pH 7.0 or pH 5.2 for 10 
min at  37°C. The cells  were  reneutralized  and 
lysed. (A) The lysates were sedimented on 5-25 % 
sucrose  gradients  containing  0.1% NP-40, frac- 
tionated,  precipitated  with the site A mAb, sepa- 
rated  on  10%  SDS-PAGE and  probed  with 
streptavidin-HRP  and  ECL.  The HA1  or  GPI- 
HA1  subunit  is  shown  with  the  corresponding 
fraction  number  listed  above  each  lane.  Frac- 
tions number 6 of the HA pH7 and GPI-HA pH7 
gradients were ,,o16.5 % in sucrose. Fraction num- 
ber 7 of the HA pH5 and fraction number 8 of the 
GPI-HA pH 5 gradients  were ,o15% in sucrose. 
The  mechanism  by  which  GPI-anchored  HA  acquires 
more complex oligosaccharides is not understood.  It is un- 
likely that GPI-anchored HA encounters different intracellu- 
lar compartments, and hence different glycosidases, because 
it is transported to the cell surface with similar efficiency and 
time course as wt-HA. Our favored hypothesis is that the GPI 
anchor leads to modifications in the structure of the HA ec- 
todomain such that the oligosaccharide chains  at Asn  165 
and 285,  which are normally sequestered,  are subjected to 
terminal glycosylation. This hypothesis is supported by three 
observations:  (a) the high mannose oligosaccharide chains 
attached  to  Asn  165  and  285  in  wt-HA  make numerous 
stabilizing contacts with the polypeptide (50);  (b) deletion 
of these oligosaccharide addition  sites yields HAs that are 
less stable or misfolded at 42°C (21);  (c) the ectodomain of 
GPI-anchored HA changes conformation at higher pH (0.4 U) 
than the wt ectodomain (Fig. 8), suggesting that it has fewer 
stabilizing contacts (reviewed in 49). 
The receptor binding defect of GPI-anchored HA could be 
due to local (near the point of membrane insertion) or long- 
range (nearer to the membrane distal receptor binding sites) 
changes in the polypeptide structure.  A  local change could 
indirectly  affect  association  of the  HA  ectodomain  with 
oligosaccharide processing enzymes. Support for this possi- 
ASN 165  RECEPTOR 
(monomer 1)  BINDING 
SITE 
'~monomer  2) 
SIDE VIEW 
;N 285 
nomer 2) 
ASN 165  ~  RECEPTOR 
BINDING 
SITE 
TOP VIEW 
Figure 11. Diagram of the HA 
trimer indicating the receptor 
binding site and the oligosac- 
charide chains at ASh 165 and 
Asn 285  of HA1. (Le~) Side 
view of  the HA trimer. (Right) 
Top view of the  HA tfimer 
demonstrating  the position of 
the  oligosaccharide  chain  at 
Ash  165 relative to the sialic 
acid binding site. 
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changes in a pH-shifted HA fusion mutant  with an amino 
acid substitution  near the base of the ectodomain (45). Alter- 
natively,  the receptor binding defect of GPI-anchored HA 
could be due to changes in the structure of the protein nearer 
to the receptor binding sites that directly allow Asn 165 of 
GPI-anchored HA to receive more complex oligosaccharide 
chains. Support for this possibility comes from biochemical 
analyses which suggest that point mutations near the base of 
the HA ectodomain can affect the packing of the globular head 
domains and vice versa (23, 27, 51, see Fig. 11). Most impor- 
tantly,  whether the structural differences in the polypeptide 
are local or long-range, our results  show, for the first time, 
that anchoring a protein to a membrane via a GPI-tail can 
lead to changes that profoundly affect a functional domain 
located at a great distance from the point of membrane in- 
sertion. 
A GPI anchor is essential for the ability of the lymphocyte 
surface proteins Qa-2 and Ly-6/E to activate T cells (34, 40). 
To explain this finding, it has been suggested that only the 
GPI-anchored forms can interact with membrane-associated 
kinases (3, 38). This could be because transmembrane or cy- 
toplasmic domains prevent association with a kinase, either 
directly or indirectly.  Alternatively,  our data suggest that the 
structures  of the GPI-anchored Qa-2 and Ly-6 ectodomains 
may be uniquely suited to interact  with transmembrane ki- 
nases or accessory proteins. More generally, the structures 
of GPI-anchored proteins may differ from their transmem- 
brane-bound  counterparts,  thus  allowing  them  to interact 
with specific factors that dictate their unique behaviors. In 
this manner,  GPI anchorage may serve as a powerful means 
for the cell to alter the structure and function of cell surface 
proteins. 
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